CT Dose Simulation Study for Appendicitis
Optimizing the Radiation Dose for CT Imaging With Iterative Reconstruction in Diagnosing Acute Appendicitis: Dose Simulation Study
1 other identifier
observational
30
1 country
1
Brief Summary
The study will explore CT radiation dose as low as reasonably achievable in diagnosing acute appendicitis, by using of dose simulation technique and iterative reconstruction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 18, 2015
CompletedFirst Posted
Study publicly available on registry
September 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedApril 12, 2017
April 1, 2017
1.5 years
September 18, 2015
April 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Diagnostic performance at original dose (2 mSv) using 5-grade Likert score for the likelihood of appendicitis assigned by each radiologist
The pooled area under curve (AUC) from three radiologists
2 months
Diagnostic performance at 75% dose (1.5 mSv) using 5-grade Likert score for the likelihood of appendicitis assigned by each radiologist
The pooled AUC from three radiologists
1 months
Diagnostic performance at 50% dose (1.0 mSv) using 5-grade Likert score for the likelihood of appendicitis assigned by each radiologist
\*The analysis of 50%-dose CT images will be performed only if non-inferiority of 75%-dose CT to the original CT is proven in terms of the pooled AUC. The pooled AUC from three radiologists
8 months
Diagnostic performance at 25% dose (0.5 mSv) using 5-grade Likert score for the likelihood of appendicitis assigned by each radiologist
\*The analysis of 25%-dose CT images will be performed only if non-inferiority of 50%-dose CT is proven to the original CT in terms of the pooled AUC. The pooled AUC from three radiologists
14 months
Secondary Outcomes (24)
Sensitivity at original dose (2 mSv) using 5-grade Likert score for the likelihood of appendicitis assigned by each radiologist
2 months
Specificity at original dose (2 mSv) using 5-grade Likert score for the likelihood of appendicitis assigned by each radiologist
2 months
Sensitivity at 75% dose (1.5 mSv) using 5-grade Likert score for the likelihood of appendicitis assigned by each radiologist
1 month
Specificity at 75% dose (1.5 mSv) using 5-grade Likert score for the likelihood of appendicitis assigned by each radiologist
1 month
Sensitivity at 50% dose (1.0 mSv) using 5-grade Likert score for the likelihood of appendicitis assigned by each radiologist
8 months
- +19 more secondary outcomes
Study Arms (1)
Suspected appendicitis
Patients who are suspected as having acute appendicitis
Interventions
Contrast-enhanced CT images of the abdomen and pelvis will be obtained during the portal venous phase using a 256-channel CT system (Philips Healthcare, Cleveland, OH). The target median dose-length product (DLP) is 130 mGy·cm, which corresponded to an effective dose of 2 mSv with a conversion factor of 0.015 mSv·mGy-1·cm-1. The radiation output was automatically adjusted according to the individual patient's body size.
Eligibility Criteria
Emergency department visit with suspected symptoms and signs of acute appendicitis.
You may qualify if:
- years of age.
- Emergency department visit with suspected symptoms and signs of acute appendicitis
- Intravenous contrast-enhanced computed tomography examination requested due to suspicion of appendicitis
You may not qualify if:
- having contraindications of intravenous contrast agent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Bunadang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ji Hoon Park, MD
Seoul National University Bundang Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
September 18, 2015
First Posted
September 22, 2015
Study Start
August 1, 2015
Primary Completion
February 1, 2017
Study Completion
March 1, 2017
Last Updated
April 12, 2017
Record last verified: 2017-04